AZD9833 China PK Study

Trial Identifier: D8530C00007
Sponsor: AstraZeneca
NCTID:: NCT04818632
Start Date: November 2021
Primary Completion Date: November 2023
Study Completion Date: November 2023

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
CN Beijing, CN, 100142
CN Chengdu, CN, 610041
CN Nanjing, CN, 210029
CN Shanghai, CN, 200032
CN Wuhan, CN, 430022
CN Zhengzhou, CN, 450008